Navigation Links
Hospitals find Theraworx highly effective thwarting costly Urinary Tract Infections
Date:8/21/2013

ASHEVILLE, N.C., Aug. 21, 2013 /PRNewswire-iReach/ -- Data from multiple in-service clinical trials and research studies involving hundreds of patients using Theraworx™ at more than a dozen hospitals are showing positive results and signaling progress battling one of the most prevalent healthcare-associated infections (HAI), catheter-associated urinary tract infections, or CAUTI.  

Theraworx is an all-natural, skin-friendly topical solution that is applied for pre-insertion and post-catheter perineal cleaning, and incontinence skin care treatment.  It has become a key factor at medical facilities adopting a patient-focus safety strategy to address CAUTIs, the greatest single source of HAIs, costing U.S. hospitals $3 billion annually.

Some 900,000 patients a year develop a CAUTI while in U.S. hospitals, and 13,000+ patients die annually when bacteria from that infection enters the kidneys, making this an important patient safety issue.  A typical 165-bed hospital can incur more than $525,000 annually in costs to fight urinary tract infections.  Medicare does not pay hospitals for CAUTI readmissions, which can cost upwards of $10,000 or more per patient.

Notable progress
Over the past three years there has been extensive data analysis from trials of Theraworx in clinical settings.  Most notably, a large academic medical center in the Midwest conducted sequential 90-day trials covering more than 400 patients in its ICU and operating rooms.  Theraworx was used prior to Foley catheter insertion for peri-care and cleaning, achieving greater than 70 percent CAUTI reduction in each test period.

"Hospitals are realizing that if they initiate a proactive program to curb CAUTI and other infections with our proven protocol that they will see improvement quickly," said Steve Woody, president of Avadim LLC.  "This is particularly significant now due to Medicare readmission penalties, pay-for-performance metrics and HAI reporting requirements that bring quite punitive consequences."

IRB studies further validate Theraworx effectiveness
Two hospital-sponsored, clinical-use research studies, both evaluated and approved by the Institutional Review Board (IRB), will be published this year that document, in detail, the use of Theraworx with a new clinical protocol that drastically curbs CAUTI.  One IRB-approved study concluded recently at 300-bed medical/ surgical hospital in Kentucky, with results expected to be published in early fall.

Produced by Avadim LLC, Theraworx is non-CHG total body pH and hygiene management solution that supports the function of the skin's natural immune system. For peri-care, a single-use 2-pack of disposable cloths is easily added to catheter bundles providing a cost-cutting, yet highly effective solution. In addition, a companion non-aerosol foam or spray bottle of Theraworx is available to continue maintenance and post-discharge incontinence care.  For more information call 877-677-2723, visit http://www.theraworx.com or write to StopCAUTI@theraworx.com.

Media Contact: Jared Buckner, Avadim LLC, 877-677-2723, jared@Theraworx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Avadim LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
2. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
3. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
4. Cases of Bed Bugs in Hospitals Hike, My Cleaning Products Recommends Non-Pesticide Bed Bug Spray to Counter Bed Bug Outbreak
5. lifeIMAGE Announces No-Cost Service for Hospitals to Give Patients Secure Access to Medical Imaging, Pledges Support for the Blue Button Initiative
6. American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified
7. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
8. Oxford University Hospitals NHS Trust and the Bodleian Libraries Select ClinicalKey
9. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
10. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
11. Narayana Hrudayalaya Hospitals Teams With Ascension Health Alliance to Build Health City at Grand Cayman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John W. ... Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical ... his FDA experience, Dr. Sheets served in senior technical leadership roles in a series ...
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... Westlake Village, CA (PRWEB) , ... August 17, ... ... biopsy technology for cancer research and personalized medicine, today announced the launch of ... in Kansas City, Missouri. The study’s goal is to evaluate the potential for ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):